EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.4.3.4 | (Z)-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride | i.e. LJP 1586. Potent, specific, and orally available inhibitor of SSAO activity is an effective anti-inflammatory compound in vivo; i.e. LJP 1586. Potent, specific, and orally available inhibitor of SSAO activity is an effective anti-inflammatory compound in vivo | Homo sapiens | |
1.4.3.21 | (Z)-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride | i.e. LJP 1586. Potent, specific, and orally available inhibitor of SSAO activity is an effective anti-inflammatory compound in vivo | Homo sapiens | |
1.4.3.21 | (Z)-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride | i.e. LJP 1586. Potent, specific, and orally available inhibitor of SSAO activity is an effective anti-inflammatory compound in vivo | Mus musculus | |
1.4.3.21 | (Z)-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride | i.e. LJP 1586. Potent, specific, and orally available inhibitor of SSAO activity is an effective anti-inflammatory compound in vivo | Rattus norvegicus | |
1.4.3.22 | (Z)-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride | i.e. LJP 1586. Potent, specific, and orally available inhibitor of SSAO activity is an effective anti-inflammatory compound in vivo | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.4.3.4 | Homo sapiens | P21397 | recombinant | - |
1.4.3.4 | Homo sapiens | P27338 | recombinant | - |
1.4.3.21 | Homo sapiens | - |
- |
- |
1.4.3.21 | Mus musculus | - |
- |
- |
1.4.3.21 | Rattus norvegicus | - |
- |
- |
1.4.3.22 | Homo sapiens | - |
recombinant | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.4.3.21 | aorta | - |
Mus musculus | - |
1.4.3.21 | lung | - |
Rattus norvegicus | - |
1.4.3.21 | umbilical cord | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.4.3.4 | benzylamine + H2O + O2 | - |
Homo sapiens | benzaldehyde + NH3 + H2O2 | - |
? | |
1.4.3.21 | benzylamine + H2O + O2 | - |
Mus musculus | benzaldehyde + NH3 + H2O2 | - |
? | |
1.4.3.21 | benzylamine + H2O + O2 | - |
Homo sapiens | benzaldehyde + NH3 + H2O2 | - |
? | |
1.4.3.21 | benzylamine + H2O + O2 | - |
Rattus norvegicus | benzaldehyde + NH3 + H2O2 | - |
? | |
1.4.3.22 | benzylamine + H2O + O2 | - |
Homo sapiens | benzaldehyde + NH3 + H2O2 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.4.3.4 | MAO-A | - |
Homo sapiens |
1.4.3.4 | MAO-B | - |
Homo sapiens |
1.4.3.21 | SSAO | - |
Mus musculus |
1.4.3.21 | SSAO | - |
Homo sapiens |
1.4.3.21 | SSAO | - |
Rattus norvegicus |
1.4.3.22 | DAO | - |
Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
1.4.3.4 | 0.0022 | - |
- |
Homo sapiens | (Z)-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride | |
1.4.3.4 | 0.098 | - |
- |
Homo sapiens | (Z)-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride | |
1.4.3.21 | 0.000004 | - |
- |
Mus musculus | (Z)-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride | |
1.4.3.21 | 0.000009 | - |
- |
Rattus norvegicus | (Z)-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride | |
1.4.3.21 | 0.000027 | - |
enzyme from umbilical cord | Homo sapiens | (Z)-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride | |
1.4.3.21 | 0.000043 | - |
lysates of human SSAO-expressing CHO cells | Homo sapiens | (Z)-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride | |
1.4.3.22 | 0.096 | - |
- |
Homo sapiens | (Z)-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride |